UTRS — Minerva Surgical Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $28.41m
- $50.29m
Annual income statement for Minerva Surgical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 26 | 37.8 | 52.1 | 50.3 |
| Cost of Revenue | ||||
| Gross Profit | 11.8 | 19.1 | 30.5 | 27.2 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 53.9 | 52.5 | 99.5 | 81.2 |
| Operating Profit | -27.9 | -14.7 | -47.4 | -30.9 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -52 | -18.4 | -21.5 | -34.1 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -52 | -18.3 | -21.5 | -34.1 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -52 | -18.3 | -21.5 | -34.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -52 | -18.3 | -21.5 | -34.1 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -30.6 | -13.1 | -6.66 | -23.7 |
| Dividends per Share |